Multiple pregnancy rate · subfertile women with polycystic ovary syndrome
Metformin showed no clear difference in multiple pregnancy rate (per woman) compared with placebo co‐treatment (low certainty).
1 finding from 1 review
Ongoing pregnancy · subfertile women with polycystic ovary syndrome
Metformin may leads to higher ongoing pregnancy rate (per woman) compared with placebo co‐treatment (low certainty).
1 finding from 1 review
Clinical pregnancy rate · subfertile women with polycystic ovary syndrome
Metformin may leads to higher clinical pregnancy rate (per woman) compared with placebo co‐treatment (low certainty).
1 finding from 1 review
Prevalence of dysmenorrhoea · women with symptomatic endometriosis
Mifepristone probably leads to lower prevalence of dysmenorrhoea compared with placebo (moderate certainty).
1 finding from 1 review
Prevalence of dyspareunia · women with symptomatic endometriosis
Mifepristone may leads to lower prevalence of dyspareunia compared with placebo (low certainty).
1 finding from 1 review
Presence of intrauterine adhesions at second‐look hysteroscopy (6‐12 weeks) · women treated by operative hysteroscopy for uterine pathology
Any anti‐adhesion therapy A may leads to lower presence of intrauterine adhesions at second‐look hysteroscopy (6‐12… compared with anti‐adhesion therapy B following operative hysteroscopy (low certainty).
1 finding from 1 review
Pregnancy rate per couple (all cycles) · couples with male subfertility
It is very uncertain whether IUI in stimulated cycles changes pregnancy rate per couple (all cycles) compared with TI (very low certainty).
2 findings from 1 review
OR 3.14 [0.12, 81.35]
Studies not reported
Very low
OR 1.51 [0.74, 3.07]
Studies not reported
Very low
Pregnancy rate per couple (all cycles) · couples with male subfertility
It is very uncertain whether IUI in stimulated cycles changes pregnancy rate per couple (all cycles) compared with IUI (very low certainty).
1 finding from 1 review
OR 1.68 [1, 2.82]
Studies not reported
Very low
Pregnancy rate per couple (all cycles) · couples with male subfertility
It is very uncertain whether IVF changes pregnancy rate per couple (all cycles) compared with IUI (very low certainty).
1 finding from 1 review
OR 1.27 [0.33, 4.97]
Studies not reported
Very low
Pregnancy rate per couple (all cycles) · couples with male subfertility
It is very uncertain whether IUI in natural cycles changes pregnancy rate per couple (all cycles) compared with TI (very low certainty).
1 finding from 1 review
OR 4.57 [0.21, 101.61]
Studies not reported
Very low
Multiple pregnancy rate · couples with male subfertility
IUI in stimulated cycles showed no clear difference in multiple pregnancy rate per couple compared with TI (low certainty).
1 finding from 1 review
OR 3.15 [0.12, 79.69]
Studies not reported
Low
Ongoing pregnancy · women undergoing assisted reproductive technology (ART)
GnRH antagonist showed no clear difference in ongoing pregnancy rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproductive technology (ART)
GnRH antagonist showed no clear difference in clinical pregnancy rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether antioestrogen changes clomiphene citrate plus tamoxifen versus clomiphene citrate ‐… compared with antioestrogen (very low certainty).
2 findings from 1 review
Clinical pregnancy · ovulation induction in polycystic ovarian syndrome
Antioestrogen plus medical adjunct showed no clear difference in clomiphene citrate plus bromocriptine versus clomiphene citrate ‐… compared with antioestrogen alone (low certainty).
1 finding from 1 review
Intervention not reported
Clinical pregnancy ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
The intervention may leads to lower clinical pregnancy ‐ Clomiphene citrate 5 days versus clomiphene… (low certainty).
1 finding from 1 review
Intervention not reported
Multiple pregnancy ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether the intervention changes multiple pregnancy ‐ Clomiphene citrate 5 days versus clomiphene… (very low certainty).
1 finding from 1 review
Intervention not reported
Clinical pregnancy ‐ Early versus late clomiphene citrate · ovulation induction in polycystic ovarian syndrome
The intervention may leads to higher clinical pregnancy ‐ Early versus late clomiphene citrate (low certainty).
1 finding from 1 review
Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome
Antioestrogen may leads to higher clinical pregnancy rate compared with placebo (low certainty).
1 finding from 1 review
Multiple pregnancy rate ‐ not reported · ovulation induction in polycystic ovarian syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found